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• Breast cancer is currently the most prevalent cancer in the
world
• Selective estrogen receptor modulators and antibody-based
therapies are effective against early-stage breast cancer
• Few treatment options exist for late-stage tumors lacking the
progesterone, estrogen, and HER2 receptors (Triple Negative
Breast Cancer)
• MCF7 breast cancer cell line represents early-stage breast
cancer due to the presence of all three target receptors
• SUM159 breast cancer cell line is triple negative, providing a
late-stage breast cancer model
• Hexylamine and epoxide product has cytotoxic effects against
HL-60 human leukemia cell line (Xie and Hansen 2019)
• What are the effects of the benzylamine and epoxide product
on the cell viability of early and late-stage breast cancer cell
lines?
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• The benzylamine-treated MCF7 cells had decreased
cell viability compared to cells treated with DMSO
• The benzylamine-treated SUM159 cells had decreased
cell viability compared to cells treated with DMSO

9

Absorbance (590nm) to 24hr Control

B

A

Discussion

8
7
Control

6

DMSO

5
*

4

3uM

*

300nM

**

3

30nM

*

3nM

2
1
0

*

24 hours

Figure 1 A) SUM159 cells B) MCF7 cells C) The chemical structure of the benzylamine and epoxide
product
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Future Work
• Continue repeating the current protocol in order to further
confirm trends of decreased cell viability in benzylaminetreated cells
• Investigate the effects of the benzylamine product on
normal human cells to ensure that benzylamine doesn’t
have cytotoxic effects on non-cancerous cells
• Confirm that benzylamine-treated cells are undergoing
apoptosis via flow cytometry.
• Investigate the effect of benzylamine on prostate cancer cell
lines
• Determine the cellular mechanisms or pathways involved in
the cytotoxic effects of benzylamine
• Investigate potential co-treatment of benzylamine and
vitamin D in breast cancer cells
• Treat MCF7 and SUM159 with other epoxide products
synthesized in Dr. Jeff Hansen’s organic chemistry lab
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Figure 2 A) SUM159 cells at 24 hours. Wells
containing only media were very confluent.
B) SUM159 cells at 72 hours. Cells flaked
off during the crystal violet staining. We
troubleshot by decreasing the number of
cells seeded to 10,000 cells per well. C)
MCF7 cells at 72 hours. Treatments were
added in replicates of 4 to randomized
wells to normalize for different evaporation
rates across the plate.

Figure 3 Cell viability in concentrations of benzylamine treatments of 3uM, 300nM, 30nM, 3nm compared to controls of cell
media and a DMSO treatment. The absorbance of crystal violet-stained cells was measured at 590nm at 24, 48, 72, and 96
hours. Each treatment average absorbance was normalized to the cell media control absorbance and. A) MCF7 cell viability.
n=3. B) SUM159 cell viability. n=2. At 24 hours n=3.
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